Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Eli Lilly
Biotech
FDA shuts down fast approval for Lilly's Alzheimer's med
Eli Lilly’s bid for an accelerated approval of Alzheimer’s disease drug donanemab has been shut down by the FDA.
Annalee Armstrong
Jan 19, 2023 7:41pm
Concert joins Sun Pharma's symphony in $576M acquisition
Jan 19, 2023 11:30am
Lilly CMO: 'We need to leave J.P. Morgan and get back to work'
Jan 9, 2023 2:36pm
Lilly pays $55M to ride TRex into regulatory T-cell space
Jan 9, 2023 9:10am
Lilly pays $55M to join AbbVie on AAV specialist's partner list
Jan 4, 2023 7:45am
Lilly doubles down on ProQR's RNA tech in $75M deal expansion
Dec 22, 2022 10:38am
